Covered recipient · General Payments record
LAUREN R GILLAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$7,323.24
- Reported across 315 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,054.56 | 92 |
| Education | $156.68 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $259.75 | 13 |
| PFIZER INC. | $180.72 | 10 |
| Incyte Corporation | $176.28 | 11 |
| Merck Sharp & Dohme Corporation | $156.41 | 6 |
| Daiichi Sankyo Inc. | $152.52 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $132.14 | 4 |
| Lilly USA, LLC | $131.40 | 2 |
| Genentech USA, Inc. | $109.00 | 4 |
| GlaxoSmithKline, LLC. | $102.65 | 4 |
| EMD Serono, Inc. | $89.53 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.40 | 3 |
| ABBVIE INC. | $73.12 | 3 |
| EISAI INC. | $66.40 | 2 |
| ARRAY BIOPHARMA INC | $61.64 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.93 | 2 |
| E.R. Squibb & Sons, L.L.C. | $46.46 | 3 |
| Janssen Biotech, Inc. | $45.43 | 2 |
| Rigel Pharmaceuticals, Inc. | $34.69 | 2 |
| BeiGene USA, Inc. | $34.08 | 1 |
| TAIHO ONCOLOGY, INC. | $27.50 | 1 |
| Gilead Sciences, Inc. | $27.23 | 1 |
| GENZYME CORPORATION | $26.48 | 1 |
| Exelixis Inc. | $26.14 | 1 |
| Karyopharm Therapeutics Inc. | $26.04 | 1 |
| Astellas Pharma US Inc | $21.57 | 1 |
| SOBI, INC | $19.20 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.20 | 1 |
| PharmaEssentia USA Corporation | $16.54 | 1 |
| Adaptive Biotechnologies Corporation | $13.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (94)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.